We are live on
!
Find out more
TC
TradeLink Capital Portfolio holdings
AUM
$13.2M
1-Year Est. Return
33.27%
This Fund
S&P 500
This Quarter
Est. Return
+1.02%
1 Year Est. Return
+33.27%
3 Year Est. Return
+48.31%
5 Year Est. Return
+69.64%
10 Year Est. Return
+1,512.66%
AUM
$324M
AUM Growth
–
Cap. Flow
+$326M
Cap. Flow
% of AUM
100.66%
Top 10 Holdings %
Top 10 Hldgs %
45.83%
Holding
412
New
412
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$87.4M |
| 2 |
Zoetis
ZTS
|
+$25.4M |
| 3 |
ExxonMobil
XOM
|
+$8.97M |
| 4 |
IBM
IBM
|
+$5.99M |
| 5 |
Philip Morris
PM
|
+$4.64M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.29% |
| 2 | Technology | 9.61% |
| 3 | Consumer Discretionary | 7.79% |
| 4 | Energy | 7.21% |
| 5 | Industrials | 6.75% |
Similar funds
PSFG
SCI
GBCP
IWM
DOFI
RC
M
AWGLSCP
TradeLink Capital's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for TradeLink Capital, which disclosed 412 positions worth $324M. Its ten largest holdings account for 46% of the portfolio.
Its largest position is Pfizer: 3,162,000 shares worth $84M.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, followed by Technology and Consumer Discretionary.
- TradeLink Capital's largest Q2 2013 buy was Pfizer: 3,162,000 shares worth $84M.
- TradeLink Capital's ten largest holdings make up 46% of its $324M portfolio in Q2 2013.
- TradeLink Capital disclosed 412 positions in Q2 2013, its first 13F filing on record.
Based on TradeLink Capital's 13F filing for Q2 2013, filed 31 Jul 2013.